Last reviewed · How we verify

NCT03875105

Daily Living Activities and Exercise Capacity in Lipid Storage Diseases

Status unknown Last updated 16 August 2023
What this trial tests

trial in Lipid Storage Disease in 25 participants. Status unknown.

Timeline
2 September 2023
Primary endpoint
4 September 2024
5 November 2024

Quick facts

Lead sponsorIstanbul University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment25
Start date2 September 2023
Primary completion4 September 2024
Estimated completion5 November 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 18 to 60, any sex, with Lipid Storage Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lipid Storage Diseases (LSD) is a group of metabolic diseases that are manifested by exercise intolerance or muscle weakness, sometimes accompanied by systemic findings, which develop in some stages of muscle contraction due to necessary lipid transfer or destruction pathways. Exercise intolerance in LSD can limit not only physical activity but also daily activities. In the literature, no study evaluated the activities of daily living in patients with LSD. The aim of this study was to investigate the effect of exercise capacity and daily living activities on the clinical features of LSD patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03875105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing